Table 4. Clinical and Laboratory... | American Society of Hematology

Table 4.

Clinical and Laboratory Findings in ET Patients and Results of Clonality Analysis Using mRNA Genes

No.	Age at Diagnosis	Follow-up Time	Treatment	C.S	Unfractionated Blood	T-Lymphocyte Fraction	Granulocyte Fraction	Platelets	Platelet Counts at Diagnosis ×10⁹/L
1^4-150	36	53	Hydrea	+	MO	MO	MO	MO	1,100
2^4-150	34	148	Hydrea	+	MO	MO	MO	MO	889
3^4-150	37	77	Interferon	−	MO	PO	MO	MO	2,160
4^4-150	80	18	Hydrea	+	MO	PO	MO	MO	812
5	21	1	0	−	MO	PO	MO	MO	1,886
6	50	57	Hydrea	+	MO	PO	MO	MO	1,700
7^4-150	33	34	Hydrea	−	MO	PO	MO	MO	1,750
8^4-150	65	49	Hydrea	−	MO	PO	MO	MO	803
9^4-150	55	100	Hydrea	+	MO	PO	MO	MO	800
10	75	52	Hydrea	−	MO	PO	MO	MO	710
11	57	98	Hydrea	−	MO	PO	MO	MO	800
12	71	1	0	−	MO	PO	MO	MO	1,150
13	69	2	0	−	MO	PO	MO	MO	900
14	69	12	Hydrea	+	MO	PO	MO	MO	2,000
15	39	1	0	−	MO	PO	MO	MO	1,400
16	77	1	0	+	MO	PO	MO	MO	650
17	69	48	0	−	MO	PO	MO	MO	787
18^4-150	65	38	Hydrea	−	MO	PO	MO	MO	745
19^4-150	48	24	Hydrea	−	MO	PO	MO	MO	1,069
20	63	123	Hydrea	−	MO	PO	MO	MO	950
21^4-150	59	120	Hydrea	−	MO	PO	MO	MO	768
22	38	1	0	−	PO	PO	PO	MO	674
23	63	1	0	+	PO	PO	PO	MO	1,200
24^4-150	71	1	0	−	PO	PO	PO	MO	751
25	24	124	0	−	PO	PO	PO	PO	950
26^4-150	25	59	0	−	PO	PO	PO	PO	751
27	25	336	0	−	PO	PO	PO	PO	780
28	43	132	0	−	PO	PO	PO	PO	600
29	30	85	Hydrea	+	PO	PO	PO	PO	648
30	37	108	Interferon	−	PO	PO	PO	PO	1,098
31	76	50	Hydrea	+	PO	PO	PO	PO	660

No.	Age at Diagnosis	Follow-up Time	Treatment	C.S	Unfractionated Blood	T-Lymphocyte Fraction	Granulocyte Fraction	Platelets	Platelet Counts at Diagnosis ×10⁹/L
1^4-150	36	53	Hydrea	+	MO	MO	MO	MO	1,100
2^4-150	34	148	Hydrea	+	MO	MO	MO	MO	889
3^4-150	37	77	Interferon	−	MO	PO	MO	MO	2,160
4^4-150	80	18	Hydrea	+	MO	PO	MO	MO	812
5	21	1	0	−	MO	PO	MO	MO	1,886
6	50	57	Hydrea	+	MO	PO	MO	MO	1,700
7^4-150	33	34	Hydrea	−	MO	PO	MO	MO	1,750
8^4-150	65	49	Hydrea	−	MO	PO	MO	MO	803
9^4-150	55	100	Hydrea	+	MO	PO	MO	MO	800
10	75	52	Hydrea	−	MO	PO	MO	MO	710
11	57	98	Hydrea	−	MO	PO	MO	MO	800
12	71	1	0	−	MO	PO	MO	MO	1,150
13	69	2	0	−	MO	PO	MO	MO	900
14	69	12	Hydrea	+	MO	PO	MO	MO	2,000
15	39	1	0	−	MO	PO	MO	MO	1,400
16	77	1	0	+	MO	PO	MO	MO	650
17	69	48	0	−	MO	PO	MO	MO	787
18^4-150	65	38	Hydrea	−	MO	PO	MO	MO	745
19^4-150	48	24	Hydrea	−	MO	PO	MO	MO	1,069
20	63	123	Hydrea	−	MO	PO	MO	MO	950
21^4-150	59	120	Hydrea	−	MO	PO	MO	MO	768
22	38	1	0	−	PO	PO	PO	MO	674
23	63	1	0	+	PO	PO	PO	MO	1,200
24^4-150	71	1	0	−	PO	PO	PO	MO	751
25	24	124	0	−	PO	PO	PO	PO	950
26^4-150	25	59	0	−	PO	PO	PO	PO	751
27	25	336	0	−	PO	PO	PO	PO	780
28	43	132	0	−	PO	PO	PO	PO	600
29	30	85	Hydrea	+	PO	PO	PO	PO	648
30	37	108	Interferon	−	PO	PO	PO	PO	1,098
31	76	50	Hydrea	+	PO	PO	PO	PO	660

Follow-up (months) at the time of clonality analysis.

Abbreviations: C.S, ischemic or hemorrhagic symptoms; MO, monoclonal; PO, polyclonal; RNA genes, G6PD or IDS or P55.

Patients reported in our previous study.14